These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32441201)

  • 1. Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury.
    Pickell Z; Williams AM; Alam HB; Hsu CH
    J Am Heart Assoc; 2020 Jun; 9(11):e016349. PubMed ID: 32441201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.
    Herr DJ; Baarine M; Aune SE; Li X; Ball LE; Lemasters JJ; Beeson CC; Chou JC; Menick DR
    J Mol Cell Cardiol; 2018 Jan; 114():309-319. PubMed ID: 29224834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
    Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
    BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures.
    Sanada S; Komuro I; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1723-41. PubMed ID: 21856909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats.
    Veveris M; Dambrova M; Cirule H; Meirena D; Kalvinsh I; Wikberg JE
    Br J Pharmacol; 1999 Nov; 128(5):1089-97. PubMed ID: 10556947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia-reperfusion injury: Complex pathophysiology with elusive treatment.
    Papageorgiou N; Briasoulis A; Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):329-330. PubMed ID: 30448621
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.
    Fessler EB; Chibane FL; Wang Z; Chuang DM
    Curr Pharm Des; 2013; 19(28):5105-20. PubMed ID: 23448466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of histone deacetylase inhibitors in brain ischemia.
    Ziemka-Nalecz M; Zalewska T
    Acta Neurobiol Exp (Wars); 2014; 74(4):383-95. PubMed ID: 25576969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective role of curcumin in myocardial ischemia-reperfusion injury.
    Mokhtari-Zaer A; Marefati N; Atkin SL; Butler AE; Sahebkar A
    J Cell Physiol; 2018 Jan; 234(1):214-222. PubMed ID: 29968913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
    Takahashi Y; Shibata T; Sasaki Y; Hirai H; Takemura S; Minamiyama Y; Sakaguchi M; Suehiro S
    Osaka City Med J; 2007 Jun; 53(1):9-16. PubMed ID: 17867629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes.
    Gundewar S; Calvert JW; Elrod JW; Lefer DJ
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2462-71. PubMed ID: 17630348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic investigations on the role of Sirt-1 in neuroprotective mechanism of postconditioning in mice.
    Kaur H; Kumar A; Jaggi AS; Singh N
    J Surg Res; 2015 Jul; 197(1):191-200. PubMed ID: 25930168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial inhibition of the ubiquitin-proteasome system ameliorates cardiac dysfunction following ischemia-reperfusion in the presence of high glucose.
    Adams B; Mapanga RF; Essop MF
    Cardiovasc Diabetol; 2015 Jul; 14():94. PubMed ID: 26216448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting autophagy for the therapeutic application of histone deacetylase inhibitors in ischemia/reperfusion heart injury.
    Zhang Y; Ren J
    Circulation; 2014 Mar; 129(10):1088-91. PubMed ID: 24396040
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtinol abrogates late phase of cardiac ischemia preconditioning in rats.
    Safari F; Shekarforoosh S; Hashemi T; Namvar Aghdash S; Fekri A; Safari F
    J Physiol Sci; 2017 Jul; 67(4):515-522. PubMed ID: 27677982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
    Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection in the Treatment of Acute Ischemic Stroke.
    Patel RAG; McMullen PW
    Prog Cardiovasc Dis; 2017; 59(6):542-548. PubMed ID: 28465001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.